Andreessen Horowitz October 15, 2024
Julie Yoo and Jay Rughani

Your access to life-saving medications shouldn’t depend on your zip code. Yet, for millions of Americans, especially in rural areas or lower-income communities, that is the reality.

Despite pharmaceutical spending in the US reaching over $700 billion each year, wide disparities in access to medications persist. The resulting inequities are particularly acute for rural communities and lower-income families, as well as for certain stigmatized populations such as those living with HIV or Hepatitis C (HCV).

Further, the clinics intended to serve these very groups, such as Federally Qualified Health Centers (FQHCs), Ryan White Clinics, and Sexually Transmitted Disease Clinics, often struggle to stay afloat financially. In particular, they lack the capabilities and capital needed to build and manage their own...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Pharma, Pharma / Biotech, Trends
Medicare's $2K drug cap starts Jan. 1
CVS, Walgreens & Walmart's healthcare strategy faces headwinds: 10 notes from 2024
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time
Mark Cuban's 2025 plans

Share This Article